MindMaze, a global leader in digital medicine for brain health, and Mount Sinai Health System, one of the largest academic medical systems in the New York metro area, are partnering to pioneer a digital therapeutic program that will accelerate neurological patient access to novel digital interventions and generate evidence-driven models to support the delivery of this care at scale, cost-effectively. This program aims to deliver superior outcomes in motor and cognitive function through high-dose, high-intensity training across the care continuum, including at the patient’s home.
“MindMaze develops digital neurotherapeutic solutions designed to elevate outcome expectations today and to accelerate the future of cognitive recovery and care. This partnership allows us to work with a world-class partner to develop evidence-driven implementation models to scale our technologies in a seamless and cost-effective way. Importantly, the collaboration will enable access to technology for patients to train intensively in the vital window of brain plasticity while extending training opportunities post-stroke,” said Dr. John Krakauer, Chief Medical Director for MindMaze.
The need for solutions that deliver superior outcomes—as well as that support patients during the lifetime of their chronic condition—has never been greater. Nearly 100 million Americans are afflicted by a neurological disease, as reported in the Annals of Neurology, resulting more often than not in costly disability that can worsen over time. Nearly 50% of the total health burden in the United States is due to morbidity and disability. While motor, cognitive, and behavioral interventions have been shown to provide benefits to those living with these conditions, research and reimbursement have lagged in these areas. Technology is the only way to scale up to the growing need.
Under this partnership, Mount Sinai will deploy an outpatient neuro-restorative program followed by a home-based digital neuro-care, assessment, and monitoring program for acute and long-term recovery after stroke and concussion, leveraging a combination of MindMaze’s software-based solutions and proprietary hardware custom built for neurological conditions. Data from the program will inform the Mount Sinai medical registry, with results supporting clinical effectiveness, scalability, and viability of the initiative.
“MindMaze and Mount Sinai are passionate about providing stroke survivors with ever improving access to care and re-defining the possibilities with neuro-recovery. This program is a manifestation of our joint ambition to redefine what is possible in neuro-recovery in a way that is not only accessible, affordable, and engaging for patients, but also seamlessly fits into physician workflows,” said Dr. David Putrino, Director of Rehabilitation Innovation for the Mount Sinai Health System.